It’s called SenSight * and it’s an anti-Parkinson’s ‘pacemaker’, a directional lead system developed by Medtronic for Deep Brain Stimulation (Dbs) therapy. “A directional stimulation that allows you to customize the therapy, and to provide individual and patient-specific data thanks to the sensing function for detecting brain signals”: these, explains the company, are the innovative features of the new device, used together with the neurostimulator. Percept * PC introduced to the market last year.
Read Also
- Friends, Sangiovanni’s hard outburst: “Enough with the intrusive gossip!” Sep 5, 2021
- World Cup 2022: “20 Minutes” verified several claims about the rules in force in Qatar Nov 23, 2022
- Building: Alexandre, roofer, recounts his daily life balancing on the roofs Nov 25, 2022
- Small UK fintech going global on backs of Visa, Railsbank Jul 12, 2021
- After the falls in the Tour: painkillers, sleep and dry needling against the infernal pain Jul 1, 2021
- IMSS approves project to guarantee workers rights Aug 31, 2021
- Motorola announced a 5G smartphone called Kiev Sep 14, 2020